Alecensa 150 MG capsule UU 240S
Ended Awarded
- Contract number
- SPE2DB25FKEMR
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,565
Award facts
- Contract value 100% obligated
- $25,564.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $25,564.66 to DMS Pharmaceutical Group Inc. for 240 units of Alecensa 150 mg capsules, with an ultimate completion date of October 16, 2025. This firm fixed-price delivery order was issued without a set-aside designation to the woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, a $499.9 million vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products to support military health facility needs worldwide.
Alecensa (alectinib) is a prescription oncology medication used in the treatment of non-small cell lung cancer. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively for delivery orders covering branded and generic prescription drugs, biologics, and medical consumables across the Department of Defense healthcare system. The company's extensive contract portfolio with DLA demonstrates consistent success in delivering specialized pharmaceutical products to military healthcare facilities nationwide.
Quick answers
Who was awarded contract SPE2DB25FKEMR?
SPE2DB25FKEMR was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FKEMR worth?
The government has obligated $25,565 on SPE2DB25FKEMR.
Is contract SPE2DB25FKEMR an order under another contract?
Yes. SPE2DB25FKEMR is a delivery order under SPE2DB24D9223, an indefinite delivery contract.
Was contract SPE2DB25FKEMR competed?
The extent of competition for SPE2DB25FKEMR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award